{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:31:54Z","timestamp":1772915514264,"version":"3.50.1"},"reference-count":50,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":6722,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1990,2]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Cyproheptadine and bromocriptine have been reported to be therapeutic in suppressing ACTH levels in Cushing's disease and Nelson's syndrome. However, there have been only scattered reports of their effect in suppressing raised ACTH levels found in patients cured of Cushing's disease by bilateral adrenalectomy. In order to assess whether these agents could prove beneficial in such patients we studied 12 patients previously treated with bilateral adrenalectomy alone for Cushing's disease before and after 3 weeks of cyproheptadine and\/or bromocroptine therapy. All had raised plasma ACTH values but no patient had evidence of a pituitary macroadenoma. Plasma ACTH and cortisol were sampled 2\u2010hourly for 24 h. Neither drug regime led to any change in plasma levels of cortisol for 24 h after a 20 mg dose of oral hydrocortisone. Plasma ACTH (mean\u00b1SEM) showed a small but significant overall reduction (523\u00b145 <jats:italic>vs<\/jats:italic> 392\u00b134 ng\/1; P &lt; 0.05) while on bromocriptine alone (5 mg given at 0800 and 1800 h, n=5). When each time point was analysed individually this reduction was significant at only five out of 13 time points. At 0400 h plasma ACTH (mean\u00b1SEM) was 7584\u00b1298.1 <jats:italic>vs<\/jats:italic> 380.2\u00b1166.6; 0600 h, 795\u00b1288.7 <jats:italic>vs<\/jats:italic> 477.8\u00b1191.7; 1200 h, 266.8\u00b1106.2 <jats:italic>vs<\/jats:italic> 187.0\u00b180.3; 1400 h, 470.0\u00b1239.0 <jats:italic>vs<\/jats:italic> 302.0\u00b1135.9; 1600 h, 548.6\u00b1262.5 <jats:italic>vs<\/jats:italic> 394.2\u00b1178.5 ng\/1 (P &lt; 0.05). There was no significant change in plasma ACTH during treatment with the combination of bromocriptine and cyproheptadine. These results do not support the routine use of these agents for patients with raised ACTH levels after bilateral adrenalectomy for Cushing's disease.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1990.tb00855.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T12:08:48Z","timestamp":1205755728000},"page":"193-201","source":"Crossref","is-referenced-by-count":24,"title":["THE EFFECT OF CYPROHEPTADINE AND\/OR BROMOCRIPTINE ON PLASMA ACTH LEVELS IN PATIENTS CURED OF CUSHING'S DISEASE BY BILATERAL ADRENALECTOMY"],"prefix":"10.1111","volume":"32","author":[{"given":"HELEN M.","family":"WHITEHEAD","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"BEACOM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"SHERIDAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. B.","family":"ATKINSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6062.686-a"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1095778"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198002213020808"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-60-2-328"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.61.713.239"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)92402-3"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1983.tb00023.x"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6068.1084"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)92451-X"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(84)80495-3"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(77)81265-1"},{"key":"e_1_2_1_13_1","first-page":"171","article-title":"Lack of responsiveness to bromocriptine of Cushing's disease elevated ACTH","volume":"3","author":"Arbol J. L.","year":"1977","journal-title":"Archivos de Farmacologia Y Toxicologia"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03349490"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197703102961022"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-54-2-413"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.54.6.466"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197608122950715"},{"key":"e_1_2_1_19_1","first-page":"171","article-title":"Cyproheptadine in the treatment of Nelson's syndrome","volume":"30","author":"Hartwig W.","year":"1979","journal-title":"Endokrynologia Polska"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj1954.31.619"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0930151"},{"key":"e_1_2_1_22_1","first-page":"77","article-title":"Cyproheptadine in the control of Cushing's disease","volume":"149","author":"Hsu T. H.","year":"1981","journal-title":"Johns Hopkins Medical Journal"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0400015"},{"key":"e_1_2_1_24_1","first-page":"305","article-title":"Cyproheptadine in Cushing's disease and Nelson's syndrome","volume":"57","author":"Jialal I.","year":"1980","journal-title":"South African Medical Journal"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/106002808201601213"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03350502"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1980.tb04494.x"},{"key":"e_1_2_1_28_1","first-page":"224","article-title":"Cushing's disease treated by total adrenalectomy: long\u2010term observation of 43 patients","volume":"52","author":"Kelly W. F.","year":"1983","journal-title":"Quarterly Journal of Medicine"},{"key":"e_1_2_1_29_1","first-page":"461","article-title":"ACTH and cortisol response to bromocriptine, and results of long term therapy in Cushing's disease","volume":"89","author":"Kennedy A. L.","year":"1978","journal-title":"Acta Endocrinologica (Copenh.)"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(82)90069-7"},{"key":"e_1_2_1_31_1","first-page":"160","article-title":"Sodium valproate and cyproheptadine may independently induce a remission in the same patient with Cushing's disease","volume":"104","author":"Koppeschaar H. P.","year":"1983","journal-title":"Acta Endocrinologica (Copenh.)"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1986.tb03621.x"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)31803-X"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-4-1-22"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197510302931802"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-46-2-349"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-43-5-1179"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0700315"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1977.tb01314.x"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-51-2-307"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-54-2-286"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)92516-8"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197608122950715"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)92585-5"},{"key":"e_1_2_1_45_1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/clinchem\/25.5.665","article-title":"A simple direct radioimmunoassay for plasma cortisol featuring a 125I radioligand and a solid phase separation technique","volume":"25","author":"Riad\u2010Fahmy D.","year":"1979","journal-title":"Clinical Chemistry"},{"key":"e_1_2_1_46_1","first-page":"1301","article-title":"Cushing's syndrome in dogs: treatment with bromocriptine and cyproheptadine","volume":"76","author":"Richkind M","year":"1981","journal-title":"Veterinary Medicine"},{"key":"e_1_2_1_47_1","first-page":"97","article-title":"Use of bromocriptine for treatment of Cushing's disease caused by an adenoma originating from the intermediate lobe of the pituitary","volume":"38","author":"Romer T. E.","year":"1987","journal-title":"Endokrynologia Polska"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197701062960128"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197611112952017"},{"key":"e_1_2_1_50_1","first-page":"436","article-title":"Prolonged remission of a case of Cushing's disease following cessation of cyproheptadine therapy","volume":"102","author":"Wiesen M.","year":"1983","journal-title":"Acta Endocrinologica (Copenh.)"},{"key":"e_1_2_1_51_1","first-page":"85","article-title":"Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report","volume":"12","author":"Zgliczynski S.","year":"1980","journal-title":"Materia Medica Polona"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1990.tb00855.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1990.tb00855.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T03:52:14Z","timestamp":1698033134000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1990.tb00855.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1990,2]]}},"alternative-id":["10.1111\/j.1365-2265.1990.tb00855.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1990.tb00855.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,2]]}}}